Expression of SRPX in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

SRPX is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 26.5

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

86.6

Number of samples

141

Samples

Sample	Description	TPM
TCGA-32-1982-01A	0 years, female, white, stage:'--, dead, 142 days	769.4
TCGA-12-3652-01A	0 years, male, white, stage:'--, dead, 1062 days	756.0
TCGA-06-0644-01A	0 years, male, black or african american, stage:'--, dead, 384 days	506.5
TCGA-27-1832-01A	0 years, female, white, stage:'--, dead, 300 days	476.1
TCGA-41-2572-01A	0 years, male, white, stage:'--, dead, 406 days	357.1
TCGA-28-5218-01A	0 years, male, white, stage:'--, dead, 157 days	323.6
TCGA-12-0619-01A	0 years, male, white, stage:'--, dead, 1062 days	306.0
TCGA-12-3653-01A	0 years, female, white, stage:'--, dead, 442 days	293.0
TCGA-06-5412-01A	0 years, female, white, stage:'--, dead, 138 days	290.4
TCGA-06-0130-01A	0 years, male, white, stage:'--, dead, 394 days	289.1
TCGA-06-5856-01A	0 years, male, white, stage:'--, dead, 114 days	283.7
TCGA-02-0055-01A	0 years, female, white, stage:'--, dead, 76 days	248.5
TCGA-41-4097-01A	0 years, female, white, stage:'--, dead, 6 days	244.6
TCGA-06-0184-01A	0 years, male, white, stage:'--, dead, 2126 days	224.1
TCGA-32-2632-01A	0 years, male, white, stage:'--, dead, 269 days	198.2
TCGA-06-0190-01A	0 years, male, white, stage:'--, dead, 317 days	186.3
TCGA-28-5204-01A	0 years, male, white, stage:'--, dead, 454 days	176.2
TCGA-19-2619-01A	0 years, female, black or african american, stage:'--, alive, 294 days	162.7
TCGA-14-0789-01A	0 years, male, white, stage:'--, dead, 342 days	161.1
TCGA-27-2528-01A	0 years, male, white, stage:'--, dead, 480 days	157.1
TCGA-06-2565-01A	0 years, male, asian, stage:'--, dead, 506 days	144.9
TCGA-19-4065-01A	0 years, male, white, stage:'--, alive, 214 days	141.0
TCGA-28-5209-01A	0 years, female, white, stage:'--, alive, 442 days	134.8
TCGA-27-2524-01A	0 years, male, white, stage:'--, dead, 231 days	130.9
TCGA-06-5410-01A	0 years, female, white, stage:'--, dead, 108 days	130.1
TCGA-26-5139-01A	0 years, female, white, stage:'--, alive, 48 days	124.9
TCGA-06-2559-01A	0 years, male, white, stage:'--, dead, 150 days	122.2
TCGA-28-2509-01A	0 years, female, white, stage:'--, alive, 145 days	104.5
TCGA-28-2514-01A	0 years, male, asian, stage:'--, alive, 160 days	94.9
TCGA-27-1835-01A	0 years, female, white, stage:'--, dead, 648 days	90.9
TCGA-14-0817-01A	0 years, female, white, stage:'--, dead, 164 days	89.7
TCGA-32-5222-01A	0 years, male, white, stage:'--, dead, 585 days	89.1
TCGA-28-5220-01A	0 years, male, white, stage:'--, dead, 388 days	88.8
TCGA-14-1034-01A	0 years, female, stage:'--, dead, 485 days	88.3
TCGA-14-2554-01A	0 years, female, white, stage:'--, dead, 532 days	86.7
TCGA-06-5416-01A	0 years, female, white, stage:'--, alive, 204 days	86.2
TCGA-06-5418-01A	0 years, female, white, stage:'--, dead, 83 days	85.9
TCGA-32-1970-01A	0 years, male, white, stage:'--, dead, 468 days	85.8
TCGA-06-0210-01A	0 years, female, white, stage:'--, dead, 225 days	83.3
TCGA-32-2638-01A	0 years, male, white, stage:'--, dead, 766 days	79.9
TCGA-06-0125-01A	0 years, female, white, stage:'--, dead, 1448 days	78.3
TCGA-76-4932-01A	0 years, female, white, stage:'--, dead, 1458 days	78.0
TCGA-41-5651-01A	0 years, female, black or african american, stage:'--, dead, 460 days	70.6
TCGA-06-5858-01A	0 years, female, white, stage:'--, alive, 187 days	67.9
TCGA-06-5408-01A	0 years, female, white, stage:'--, dead, 357 days	67.5
TCGA-06-2557-01A	0 years, male, black or african american, stage:'--, dead, 33 days	66.2
TCGA-12-5295-01A	0 years, female, white, stage:'--, dead, 454 days	65.8
TCGA-06-2564-01A	0 years, male, white, stage:'--, alive, 181 days	64.0
TCGA-19-2629-01A	0 years, male, white, stage:'--, dead, 737 days	62.1
TCGA-28-2513-01A	0 years, female, white, stage:'--, alive, 222 days	61.7
TCGA-27-2523-01A	0 years, male, white, stage:'--, dead, 489 days	61.3
TCGA-06-0187-01A	0 years, male, white, stage:'--, dead, 828 days	61.2
TCGA-27-1830-01A	0 years, male, white, stage:'--, dead, 154 days	58.6
TCGA-28-5207-01A	0 years, male, white, stage:'--, dead, 343 days	58.0
TCGA-27-1837-01A	0 years, male, white, stage:'--, dead, 427 days	58.0
TCGA-06-0141-01A	0 years, male, white, stage:'--, dead, 313 days	53.9
TCGA-27-2521-01A	0 years, male, white, stage:'--, dead, 510 days	53.6
TCGA-41-3915-01A	0 years, male, white, stage:'--, dead, 360 days	52.6
TCGA-28-5216-01A	0 years, male, white, stage:'--, alive, 415 days	52.1
TCGA-76-4931-01A	0 years, female, white, stage:'--, dead, 279 days	51.6
TCGA-06-2561-01A	0 years, female, white, stage:'--, dead, 537 days	51.5
TCGA-06-2563-01A	0 years, female, white, stage:'--, alive, 932 days	51.4
TCGA-14-1823-01A	0 years, female, white, stage:'--, dead, 543 days	50.6
TCGA-19-2620-01A	0 years, male, white, stage:'--, dead, 148 days	50.0
TCGA-12-0821-01A	0 years, male, white, stage:'--, dead, 323 days	49.4
TCGA-06-0211-01A	0 years, male, white, stage:'--, dead, 360 days	49.3
TCGA-06-2562-01A	0 years, male, white, stage:'--, dead, 382 days	49.0
TCGA-28-5208-01A	0 years, male, white, stage:'--, dead, 544 days	47.7
TCGA-06-2569-01A	0 years, female, black or african american, stage:'--, alive, 13 days	47.5
TCGA-06-5417-01A	0 years, female, white, stage:'--, alive, 155 days	47.1
TCGA-06-0174-01A	0 years, male, white, stage:'--, dead, 98 days	46.7
TCGA-32-4213-01A	0 years, female, white, stage:'--, alive, 604 days	45.6
TCGA-06-0157-01A	0 years, female, white, stage:'--, dead, 97 days	45.5
TCGA-08-0386-01A	0 years, male, white, stage:'--, dead, 548 days	44.8
TCGA-27-2526-01A	0 years, female, white, stage:'--, dead, 87 days	44.7
TCGA-28-5215-01A	0 years, female, white, stage:'--, dead, 335 days	44.5
TCGA-06-0168-01A	0 years, female, white, stage:'--, dead, 598 days	44.2
TCGA-12-0616-01A	0 years, female, white, stage:'--, dead, 448 days	43.3
TCGA-06-0745-01A	0 years, male, white, stage:'--, dead, 239 days	43.2
TCGA-19-2624-01A	0 years, male, white, stage:'--, dead, 5 days	42.3
TCGA-06-0646-01A	0 years, male, white, stage:'--, dead, 175 days	41.6
TCGA-32-1980-01A	0 years, male, white, stage:'--, dead, 36 days	39.6
TCGA-12-5299-01A	0 years, female, white, stage:'--, dead, 98 days	39.5
TCGA-27-2519-01A	0 years, male, white, stage:'--, dead, 550 days	38.9
TCGA-19-5960-01A	0 years, male, white, stage:'--, dead, 455 days	38.9
TCGA-76-4927-01A	0 years, male, white, stage:'--, dead, 535 days	37.7
TCGA-32-2615-01A	0 years, male, white, stage:'--, dead, 485 days	37.6
TCGA-06-0645-01A	0 years, female, white, stage:'--, dead, 175 days	37.0
TCGA-06-0743-01A	0 years, male, white, stage:'--, dead, 803 days	35.9
TCGA-15-1444-01A	0 years, male, white, stage:'--, dead, 1537 days	34.9
TCGA-19-2625-01A	0 years, female, white, stage:'--, dead, 124 days	34.1
TCGA-02-0047-01A	0 years, male, white, stage:'--, dead, 448 days	34.0
TCGA-27-1834-01A	0 years, male, white, stage:'--, dead, 1233 days	34.0
TCGA-06-0139-01A	0 years, male, white, stage:'--, dead, 362 days	32.2
TCGA-32-2616-01A	0 years, female, white, stage:'--, dead, 224 days	32.0
TCGA-14-1829-01A	0 years, male, black or african american, stage:'--, alive, 218 days	31.9
TCGA-28-1753-01A	0 years, male, white, stage:'--, alive, 37 days	30.8
TCGA-76-4925-01A	0 years, male, white, stage:'--, dead, 146 days	30.7
TCGA-41-2571-01A	0 years, male, white, stage:'--, dead, 26 days	29.8
TCGA-06-0686-01A	0 years, male, white, stage:'--, dead, 432 days	29.6
TCGA-06-0747-01A	0 years, male, white, stage:'--, dead, 82 days	29.1
TCGA-06-0138-01A	0 years, male, white, stage:'--, dead, 737 days	29.1
TCGA-12-3650-01A	0 years, male, white, stage:'--, dead, 333 days	29.0
TCGA-06-0882-01A	0 years, male, white, stage:'--, dead, 632 days	28.8
TCGA-06-0132-01A	0 years, male, white, stage:'--, dead, 771 days	28.7
TCGA-02-2486-01A	0 years, male, white, stage:'--, dead, 618 days	28.6
TCGA-06-0878-01A	0 years, male, white, stage:'--, alive, 218 days	28.5
TCGA-15-0742-01A	0 years, male, white, stage:'--, dead, 419 days	28.3
TCGA-26-5135-01A	0 years, female, white, stage:'--, dead, 270 days	27.6
TCGA-16-0846-01A	0 years, male, white, stage:'--, dead, 119 days	26.8
TCGA-12-0618-01A	0 years, male, white, stage:'--, dead, 395 days	26.5
TCGA-06-5414-01A	0 years, male, white, stage:'--, alive, 273 days	26.5
TCGA-06-0158-01A	0 years, male, white, stage:'--, dead, 329 days	25.7
TCGA-06-2558-01A	0 years, female, white, stage:'--, dead, 380 days	25.5
TCGA-06-5859-01A	0 years, male, white, stage:'--, alive, 139 days	25.0
TCGA-06-0219-01A	0 years, male, white, stage:'--, dead, 22 days	24.5
TCGA-76-4929-01A	0 years, female, white, stage:'--, dead, 111 days	24.0
TCGA-06-0750-01A	0 years, male, white, stage:'--, dead, 28 days	23.8
TCGA-06-0178-01A	0 years, male, white, stage:'--, dead, 2681 days	23.5
TCGA-14-0871-01A	0 years, female, white, stage:'--, dead, 880 days	21.7
TCGA-26-5133-01A	0 years, male, white, stage:'--, alive, 452 days	20.6
TCGA-27-1831-01A	0 years, male, white, stage:'--, dead, 505 days	19.8
TCGA-06-0749-01A	0 years, male, black or african american, stage:'--, dead, 82 days	19.5
TCGA-06-2570-01A	0 years, female, white, stage:'--, alive, 958 days	18.1
TCGA-06-5413-01A	0 years, male, white, stage:'--, alive, 268 days	18.1
TCGA-26-1442-01A	0 years, male, white, stage:'--, alive, 953 days	17.4
TCGA-14-1825-01A	0 years, male, white, stage:'--, dead, 232 days	17.4
TCGA-26-5132-01A	0 years, male, white, stage:'--, alive, 286 days	17.3
TCGA-02-2485-01A	0 years, male, black or african american, stage:'--, alive, 470 days	16.2
TCGA-32-2634-01A	0 years, male, white, stage:'--, alive, 693 days	15.8
TCGA-06-0744-01A	0 years, male, white, stage:'--, dead, 1426 days	15.5
TCGA-06-2567-01A	0 years, male, white, stage:'--, dead, 133 days	14.6
TCGA-06-1804-01A	0 years, female, white, stage:'--, dead, 414 days	14.5
TCGA-06-0156-01A	0 years, male, white, stage:'--, dead, 178 days	14.1
TCGA-06-0129-01A	0 years, male, asian, stage:'--, dead, 1024 days	12.5
TCGA-19-1390-01A	0 years, female, white, stage:'--, dead, 772 days	12.5
TCGA-06-0238-01A	0 years, male, white, stage:'--, dead, 405 days	11.7
TCGA-26-5134-01A	0 years, male, white, stage:'--, alive, 167 days	10.4
TCGA-06-5411-01A	0 years, male, white, stage:'--, dead, 254 days	9.6
TCGA-02-2483-01A	0 years, male, asian, stage:'--, alive, 466 days	8.1
TCGA-14-0787-01A	0 years, male, asian, stage:'--, dead, 68 days	6.0
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

SRPX is potential prognostic, high expression is unfavorable in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 9.7

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

34.1

Number of samples

Samples

Sample	Description	TPM
AK153	N, NA, stage:NA, dead, 240 days	259.6
AK195	N, NA, stage:NA, dead, 390 days	150.3
AK227	N, NA, stage:NA, alive, 300 days	117.7
AK226	N, NA, stage:NA, dead, 360 days	97.3
AK178	N, NA, stage:NA, dead, 240 days	78.1
AK098	N, NA, stage:NA, dead, 660 days	74.0
AK088	N, NA, stage:NA, dead, 360 days	71.9
AK139	N, NA, stage:NA, dead, 270 days	71.7
AK068	N, NA, stage:NA, alive, 360 days	56.5
AK133	N, NA, stage:NA, dead, 360 days	55.9
AK185	N, NA, stage:NA, alive, 330 days	54.8
AK076	N, NA, stage:NA, alive, 660 days	45.5
AK099	N, NA, stage:NA, dead, 420 days	43.3
AK183	N, NA, stage:NA, alive, 360 days	41.8
AK035	N, NA, stage:NA, dead, 210 days	38.5
AK049	N, NA, stage:NA, dead, 180 days	38.3
AK100	N, NA, stage:NA, alive, 960 days	35.4
AK123	N, NA, stage:NA, dead, 180 days	35.1
AK089	N, NA, stage:NA, dead, 330 days	35.0
AK081	N, NA, stage:NA, dead, 180 days	34.9
AK188	N, NA, stage:NA, alive, 420 days	32.5
AK216	N, NA, stage:NA, dead, 360 days	31.5
AK030	N, NA, stage:NA, dead, 120 days	27.7
AK072	N, NA, stage:NA, dead, 150 days	25.4
AK055	N, NA, stage:NA, dead, 240 days	22.3
AK218	N, NA, stage:NA, dead, 180 days	21.8
AK053	N, NA, stage:NA, dead, 300 days	21.5
AK074	N, NA, stage:NA, alive, 300 days	21.4
AK156	N, NA, stage:NA, dead, 330 days	20.8
AK091	N, NA, stage:NA, dead, 210 days	20.3
AK231	N, NA, stage:NA, dead, 240 days	17.4
AK102	N, NA, stage:NA, alive, 1740 days	17.1
AK071	N, NA, stage:NA, dead, 540 days	17.0
AK205	N, NA, stage:NA, dead, 120 days	15.7
AK051	N, NA, stage:NA, dead, 360 days	15.2
AK015	N, NA, stage:NA, alive, 720 days	15.2
AK117	N, NA, stage:NA, dead, 210 days	14.8
AK079	N, NA, stage:NA, dead, 210 days	14.4
AK167	N, NA, stage:NA, dead, 180 days	14.4
AK236	N, NA, stage:NA, dead, 360 days	13.4
AK142	N, NA, stage:NA, alive, 90 days	13.4
AK149	N, NA, stage:NA, dead, 420 days	13.4
AK006	N, NA, stage:NA, dead, 360 days	13.3
AK173	N, NA, stage:NA, dead, 180 days	11.7
AK003	N, NA, stage:NA, dead, 600 days	9.8
AK199	N, NA, stage:NA, alive, 1860 days	9.6
AK134	N, NA, stage:NA, dead, 360 days	9.6
AK085	N, NA, stage:NA, alive, 660 days	9.4
AK165	N, NA, stage:NA, alive, 360 days	8.8
AK158	N, NA, stage:NA, dead, 360 days	8.7
AK103	N, NA, stage:NA, alive, 1320 days	7.8
AK213	N, NA, stage:NA, alive, 2010 days	7.8
AK005	N, NA, stage:NA, dead, 240 days	5.9
AK043	N, NA, stage:NA, alive, 660 days	5.3
AK002	N, NA, stage:NA, dead, 570 days	5.2
AK124	N, NA, stage:NA, alive, 1920 days	4.4
AK066	N, NA, stage:NA, alive, 960 days	3.1
AK041	N, NA, stage:NA, alive, 810 days	0.4
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0093450003	Tumor	3.4
CPT0123530003	Tumor	2.8
CPT0168080003	Tumor	2.0
CPT0127480003	Tumor	1.4
CPT0225760003	Tumor	1.1
CPT0087950003	Tumor	1.1
CPT0206230003	Tumor	1.0
CPT0207030003	Tumor	0.9
CPT0205570003	Tumor	0.8
CPT0087570003	Tumor	0.8
CPT0218330004	Tumor	0.7
CPT0205890003	Tumor	0.7
CPT0078580003	Tumor	0.7
CPT0167530003	Tumor	0.7
CPT0217430008	Tumor	0.6
CPT0206880003	Tumor	0.6
CPT0217000004	Tumor	0.5
CPT0092440003	Tumor	0.4
CPT0190360004	Tumor	0.4
CPT0218890004	Tumor	0.4
CPT0079790003	Tumor	0.3
CPT0218690004	Tumor	0.3
CPT0162020003	Tumor	0.3
CPT0189750004	Tumor	0.3
CPT0206000004	Tumor	0.2
CPT0002410011	Tumor	0.2
CPT0125220003	Tumor	0.2
CPT0087680003	Tumor	0.1
CPT0093550003	Tumor	0.1
CPT0217100003	Tumor	0.1
CPT0218670003	Tumor	0.1
CPT0167640003	Tumor	0.1
CPT0167970003	Tumor	0.1
CPT0182580003	Tumor	0.0
CPT0189460003	Tumor	0.0
CPT0087730003	Tumor	0.0
CPT0216920008	Tumor	-0.1
CPT0064890003	Tumor	-0.2
CPT0206110003	Tumor	-0.3
CPT0189650004	Tumor	-0.3
CPT0093360003	Tumor	-0.3
CPT0228220003	Tumor	-0.3
CPT0167750004	Tumor	-0.3
CPT0217710008	Tumor	-0.3
CPT0217190003	Tumor	-0.3
CPT0196850003	Tumor	-0.3
CPT0206560003	Tumor	-0.4
CPT0171580008	Tumor	-0.4
CPT0168590003	Tumor	-0.4
CPT0206450003	Tumor	-0.4
CPT0209440003	Tumor	-0.4
CPT0218770003	Tumor	-0.5
CPT0125570003	Tumor	-0.5
CPT0218960004	Tumor	-0.5
CPT0071100003	Tumor	-0.5
CPT0218830004	Tumor	-0.5
CPT0175060003	Tumor	-0.5
CPT0189850004	Tumor	-0.5
CPT0208980003	Tumor	-0.5
CPT0162100003	Tumor	-0.6
CPT0219080004	Tumor	-0.6
CPT0205450004	Tumor	-0.6
CPT0217880003	Tumor	-0.6
CPT0205670004	Tumor	-0.6
CPT0224600003	Tumor	-0.6
CPT0186100003	Tumor	-0.6
CPT0168830003	Tumor	-0.6
CPT0205780003	Tumor	-0.7
CPT0127420003	Tumor	-0.7
CPT0224540004	Tumor	-0.7
CPT0225730003	Tumor	-0.7
CPT0217060003	Tumor	-0.7
CPT0168480003	Tumor	-0.7
CPT0221180003	Tumor	-0.8
CPT0168720003	Tumor	-0.8
CPT0189250003	Tumor	-0.8
CPT0093510003	Tumor	-0.8
CPT0189570004	Tumor	-0.9
CPT0224390004	Tumor	-0.9
CPT0089150003	Tumor	-0.9
CPT0206780003	Tumor	-1.0
CPT0204420003	Normal	-1.0
CPT0168270003	Tumor	-1.0
CPT0093590003	Tumor	-1.0
CPT0168380003	Tumor	-1.0
CPT0182500003	Tumor	-1.0
CPT0182550003	Tumor	-1.1
CPT0206670004	Tumor	-1.1
CPT0104330003	Tumor	-1.1
CPT0064650003	Tumor	-1.1
CPT0125510003	Tumor	-1.1
CPT0104220003	Tumor	-1.1
CPT0167860004	Tumor	-1.1
CPT0199770003	Tumor	-1.1
CPT0190240004	Tumor	-1.2
CPT0207090003	Tumor	-1.2
CPT0204360003	Normal	-1.2
CPT0206330003	Tumor	-1.3
CPT0204370003	Normal	-1.3
CPT0161730003	Tumor	-1.4
CPT0204410003	Normal	-1.4
CPT0201710003	Tumor	-1.5
CPT0204350003	Normal	-1.5
CPT0204390003	Normal	-1.7
CPT0204330003	Normal	-1.7
CPT0204340003	Normal	-1.8
CPT0204380003	Normal	-1.8
CPT0204400003	Normal	-1.9
CPT0162140003	Tumor	-2.0
CPT0224330003	Tumor	-2.6
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis